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Taxine B (3), iso lated  from  th e  dried  needles of Taxus baccata, was converted into six novel 
7-deoxypaclitaxel analogs, 2 0 , 2 1 a ,b , and  2 3 -2 5 , th a t  have s tru c tu ra l changes a t C l, C2 , and C4. 
A method for th e  in troduction  of th e  benzoyl function a t C2, v ia  a benzylidene acetal a t C l—C2, 
will be revealed. All com pounds showed very little  or no m easurab le cytotoxic activity against 
some w ell-characterized hum an  tum or cell lines, probably due to th e  nonacylated hydroxyl group
a t C4.
The diterpenoid paclitaxel (1) (C h art 1), f irs t isolated 
by W ani and W all1 from  th e  b a rk  of th e  w estern  yew 
Taxus brevifolia, is a new  and  very  prom ising an titum or 
compound.2 The s tru c tu ra l complexity of (1), and its  
unique mechanism of action ,3 have stim ulated  extensive 
research  toward th e  synthesis of paclitaxel as well as the  
synthesis of new analogs. U n til recently , th e  synthesis 
of paclitaxel has been achieved both  by sem isynthesis ,4 
s ta rtin g  from 10-deacetylbaccatin III (2) (C hart 1), and  
by to ta l synthesis.5
The synthesis of analogs for s tru c tu re—activity re la­
tionship (SAR) studies have m ostly been accomplished 
by structurally  modifying paclitaxel itself.6 In  several 
cases, precursors, such as baccatin  I I I ,7 brevifoliol,8 13- 
acetyl-9-dihydrobacatin I I I ,9 and  14-/Miydroxy-10-des- 
acetylbaccatin ,10 isolated from  th e  needles of different 
Taxus species, were used.
C h a r t 1
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Taxine B (3), th e  m ost abundant precursor present in 
th e  needles of Taxus baccata L, (C hart 1), has had little 
a tten tion  paid to it  as a precursor for either the synthesis 
of paclitaxel or for the synthesis of its analogs. To our 
knowledge, only one investigation11 to date has been 
carried  out using  taxine B as a starting  m aterial. This 
synthesis, however, did not lead to analogs th a t possessed 
th e  necessary /3-amino acid side chain. A retro synthetic 
analysis showed th a t the synthesis of paclitaxel itself 
from tax ine B would require more th an  20 steps. The 
in troduction  of th e  7-hydroxyl group, in particular, was 
expected to be difficult. We concentrated our efforts on 
the  synthesis of 7-deoxypaclitaxel analogs, when in  in 
vitro assays i t  w as shown th a t  the  7 -hydroxyl group had 
practically no effect on activity .12
From  SAR studies it is known th a t  the oxetane ring ,13 
the  paclitaxel side chain ,14 and the hydroxyl group15 at
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J.; Plattner, J. J. J. Med. Chem. 1995, 38, 1482-1492.
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4, 1565-1570.
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C2' are  im portan t for cytotoxic activity and th a t the  
functional groups a t the upper side of paclitaxel, positions 
C7,12 C9,9,16 and C10,9’12b’16 are of less importance for 
cytotoxic activity. The bottom side of paclitaxel, positions 
C l, C2 , and  C4, was a black box a t the s ta rt of our 
research. In  this paper, we present the synthesis of some 
7-deoxypaclitaxel analogs (20, 21a,b, and 23 -25 ) w ith  
structu ral changes a t  C l, C2 , and C4. At positions C9 
and CIO, all the  analogs have either free hydroxyl groups 
or hydroxyl groups protected by an isopropylidene func­
tionality. The introduction of the C2-benzoate function­
ality was no t possible by earlier described methods. 
Therefore, a  method has been developed to introduce the  
benzoate group via oxidation of the benzylidene acetal.
R e su lts
Crude tax ine B can easily be isolated, without chro­
matographic steps, from the needles of the European yew, 
Taxus baccata L., in  yields of 12 g per kg of dried leaves, 
by an  extraction m ethod based on procedures described 
by Lucas and  Graf.17 The yield of 10-deacetylbaccatin 
III, the  precursor used in the synthesis of paclitaxel, from 
these needles is a t least five times less.18 Crude tax ine
B, therefore, seemed to be an  excellent precursor for the  
synthesis of 7-deoxypaclitaxel analogs.
A closer investigation of isolated crude taxine B 
showed19 th a t  it  was a m ixture of several compounds, 
40% of w hich had a taxane skeleton (4a—f). No fu rther 
purification was necessary, however, because the com­
pounds w ith  the taxane skeleton were easily separated 
from th e  o ther compounds by crystallization as am ­
monium sa lts  after reaction with methyl iodide. The 
complete conversions of the crude taxine B mixture 4 a ~ f  
into th e  protected 7-deoxypaclitaxel derivatives 15a—c 
are p resen ted  in Scheme 1. The preparation of the
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Mostly, much lower yields, however, are reported in the literature.1813 
Furthermore, the isolation of the taxines is much less labor intensive 
and also less expensive. No organic solvents are required in the initial 
extraction procedure and no chromatographic steps are needed for the 
purification, (b) ElSohly, H. N.; Croom, E, M.; Kopycki, W. J,; Joshi, 
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in term edia tes 14 w as carried  ou t analogously to an  
approach of E tto u a ti e t a l .11 for 14b, although we have 
m ade some m odifications to  the  synthetic route. After 
these am m onium  sa lts  w ere collected by filtra tion , tri- 
m ethylanunonium  iodide w as elim inated by K 2CO3 to 
give a m ix tu re  of 5 a —f. In  the next step , th e  acetyl 
groups were rem oved w ith  1.2 equiv of sodium m ethoxide 
to give a m ix tu re  of 6a,b . Selective introduction of the  
acetonide bridge a t 6a ,b  using  acetone and CUSO4 yielded 
a m ixture of 7a,b . A t th is  stage th e  first purification by 
chrom atography w as carried  out. Separation of 7 a  and 
7b w as unsuccessful, however. The yield of 7 a ,b  was 
55% s ta r tin g  from 5 a —f. T reatm ent of the  m ix tu re  of 
7a,b  w ith  dihydropyran, acetone, or the d im ethyl acetal 
of benzaldehyde, respectively, yielded 8a , 8b ,20 and 8 c, 
respectively, m ixed w ith  7b. A t th is stage it w as possible 
to sep ara te  com pound 7b  (14%), which itse lf  is an  
in te resting  p recursor for th e  synthesis of 1-deoxypacli­
taxel analogs ,21 from  compounds 8 a,b ,c (82, 73, and  85%) 
by chrom atography. In  order to discrim inate betw een 
th e  OH groups a t  C l, C2, C9, and CIO, the  te trahydro- 
pyranyl-protected com pound 8a  was prepared. We ex­
pected th a t  the te trahyd ropy rany l groups could be re ­
moved independently from the isopropylidene functionality 
as well as from  each other. The benzylidene functionality 
(8c) w as selected because i t  is possible to convert it into 
a benzoyl group by oxidation .22
Since all the  hydroxyl groups were protected as acetals, 
it was possible to rem ove th e  cinnamoyl side chain 11 w ith 
20 N  N aO H , yielding com pounds 9a,b ,c  (95, 93, and 
76%). Conversion of th e  allylic alcohol function into an 
oxetane ring  was achieved by established m ethods .11,23 
D ihydroxylation w ith  osm ium  tetraoxide gave 10a,b ,c  
(75, 87, and  55%). Protection of th e  prim ary alcohol w ith 
ieri-butyld im ethylsily l chloride and  m esylation of the  
secondary alcohol gave 1 1 a ,b ,c  (85, 81, and  77%). From 
compound 1 1 a  we followed two routes to com pound 14a. 
The firs t rou te  (11a v ia 12a to 14a) had  a lready  been 
worked ou t by E tto u a ti e t a l .11 in  the p repara tion  of 
compound 14b from  l i b .  Removal of the  ieri-butyldi- 
m ethylsilyl group w ith  BiL)N+ “F, followed by ring  closure 
w ith  B u4N + "OAc, yielded 12a (75%). R eduction of the  
carbonyl a t  C l3 w ith  DIBALH gave th e  a-isom er 14a 
(3 7 % from  1 1 a; th e  /3-isomer was isolated in  1 1 % yield). 
In  order to find a more selective reduction of th e  carbonyl 
group a t  C13 by a d ifferent route (11a via 13a  to 14a) 
th is carbonyl of 1 1 a  w as f irs t reduced by DIBALH. U se 
of m odels and  calcu lations24 indicated th a t  th e  mesyl 
functionality  a t C5 is able to shield the back side of the
(20) Compounds 8b-14b were prepared as reported by Ettouati et 
al, The ^-NMR spectra of 8b—14b were in agreement with those in 
the literature; also, see ref 12.
(21) (a) Compound 7b was difficult to purify. Therefore, the C2-OH 
of 7b was protected with trimethylsilyl chloride. This silylated 
compound was then fully characterized; see also the supporting 
information, (b) In a similar way as described for 8 a -c  in this paper, 
compound 7b can be converted into 1,7-dideoxypaclitaxel analogs (to 
be published).
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carbonyl a t  C13. The a ttack  of a  hydride, therefore, can 
only take place from th e  front side. Indeed, only th e  
a-isomer, 13a, w as formed; th e  /?-isomer was not de­
tected. U nfortunately , 13a  w as iso lated  in  only 45%
(24) dilations were carried out with the computer program
and CS Chem3D Pro (version 3.2).
R^ O r ^ Q  VÌÒ
14a,b,c
yield. From  the rem aining 55%, about 30% was lost as 
a re su lt of column chromatography. The other 25% 
consisted of several products th a t were not further 
identified. The reduction was not studied further at this 
stage although it  may be optimized by using other 
(leaving) groups instead of the mesyl functionality. 
D esilylation w ith Bu4N+ “F followed by treatm ent with
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Scheme 2 S c h e m e  3
H20 /H 0 A c /T H F  
2 / 2 / 1
12a
pyridine
▼
b h 3,t h f
— - —  o
X /'  O r r N
17
DMAP
Bu4N+ “OAC yielded 14a (36% from 1 1 a). The yield of 
14a, therefore, was about the same for both routes, 
although purification by column chromatography after 
each step  appeared to be m uch more difficult for route 
2, probably due to the early reduction step th a t yielded 
too m any side products. For th is reason, compounds 14b 
(24%) and  14c (29%) were synthesized from l i b  and 11c, 
respectively, by the first route. Coupling of compounds 
14a,b ,c w ith  the oxazinone side chain, according to th e  
protocol described by Holton,25 gave the protected analogs 
of 7-deoxypaclitaxel, 15a,b ,c (89%, 66%, and 70%).
Protected analog 19 was synthesized as depicted in  
Scheme 2. S tarting  from compound 12a, the hydroxyl 
groups a t  C l and C2 were firs t deprotected, after which 
th e  benzoate group was introduced a t C2. I t appeared, 
however, not to be possible to hydrolyze both THP groups. 
Only th e  TH P group a t C l was hydrolyzed, yielding 16 
(89%), as became clear after the free hydroxyl group w as 
benzoylated w ith benzoyl chloride in pyridine, yielding 
17 (96%). The 400 MHz aH-NMR spectrum of compound 
17 showed no downfield shift of the proton at C2 as would 
be expected if the benzoate group is attached to C2 (4.14 
ppm in 16 and 4.15 ppm  in  17). In order to achieve 
selective reduction of the  C13 carbonyl and avoid reduc-
H20  I HOAc / THF 
2 1 2 / 1
15a
15b
1 1
H20  / HOAc / THF 
2 1 4 / 1
40 OC
20
i  i
R60 HO
21a R5 = H, RB = tetrahydropyrany!
21b R5 R6= Me Me
/ \
tion of th e  benzoyl group, we tried  several reducing 
agents including BH3—TH F, N aBH 4, LiBH4) and  K- 
selectride. The best results were obtained after reduction 
w ith B H g-TH F, although in  th is case concomitant reduc­
tion of the  C l l —C 12 double bond could not be avoided. 
The obtained yield of 18, therefore, was only 21%. 
Coupling of 18 w ith th e  paclitaxel side chain by the 
m ethod described above yielded 19 (80%).
D eprotection of the 7-deoxypaclitaxel analogs 1 5 a—c 
and 19 w as performed by acid hydrolysis. T rea tm en t of 
15a w ith  a  2/2/1 m ixture of H 2O/HOAc/THF provided 20 
(76%), as shown in  Scheme 3. U sing a 2/4/1 m ixture a t 
40 °C, th e  isopropylidene functionality  at C9,C10 of 15a 
and  15b, respectively, w as also hydrolyzed, yielding 2 1a  
(63%) and 21b (66%). U nfortunately , it was n o t possible 
to remove the TH P group a t C2 of compound 21a or to 
remove th e  isopropylidene functionality a t  C1 ,C2 of 
compound 21b  w ithout destruction  of other p a rts  of the 
molecule, Recently, analogous problems w ith  th e  hy­
drolysis of th e  isopropylidene functionality of a re la ted  
taxane com pound have been reported by Nicolaou e t a l.26
Compound 23 was iso la ted  in  68% yield a fte r depro­
tection of compound 15c w ith  a 2/4/1 m ixture of H 2O/ 
HOAc/THF a t 40 °C, as shown in  Scheme 4. Deprotection 
of compound 15c w ith a 2/2/1 m ixture of H 2O/HOAc/THF 
a t  room tem p era tu re  gave 22 in  73% yield.
Due to the  surprising  acid stability of an  acetal 
protecting functionality  a t  C2, i t  is not possible to 
introduce the  necessary benzoate group a t  C2 via 
benzoylation of an  OH group a t  the C2 position. Taking 
th is into account, we rationalized  th a t the benzoate group 
m ay be selectively in troduced at C2 via oxidation of a 
benzylidene aceta l a t C l, C2 . For the  oxidation of the 
benzylidene functionality  to a  benzoyl group we tried  
several m ethods .22 B est re su lts  were obtained w hen the 
benzylidene functionality  a t  C1,C2 of 22 was oxidized by 
¿-BuOOH in  th e  presence of a  catalytic am ount of Pd- 
(OAc)2 to yield compound 24 (28%), with a 55% recovery 
of compound 2 2 .
(25) Holton, R. A. European Patent 1991, EP 0428376Al.
(26) Nicolaou, K. C.; Guy, R. K. Angew. Chem. 1995, 107, 2247 
2259.
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Acid hydrolysis of compound 19 to  give 25 (Scheme 5) 
appeared to be ra th e r  difficult. In  a 4/2/1 m ixture of 
Ac0H/H20/T H F a t 50 °C, th e  isopropylidene functionality 
was not hydrolyzed. I t  w as necessary  to use a 12/2/1 
m ixture of A c0H /H 20 /T H F  a t  50 °C. U nder these 
conditions th e  paclitaxel side chain  w as sp lit off for 32%. 
N evertheless, we were able to iso late 25 in  61% yield.
Structure Determ ination of Compound 23
The struc tu re  of 23 is p resum ed to be as draw n in 
Scheme 4. The configurations a t C4, C5, C13, and C4' 
(for num bering see 23, Scheme 4) w ere confirmed by NOE 
difference experim ents. The following NOE contacts
were found: H (2)-H (9); H (2 )-C H 3(17); H (2 )-C H a(19); 
H (2)-H (4 '); H (9 )-C H 3(19); H (13)-H (14/%  H (13)-C H 3- 
(16); H( 14/3)—CH3( 16), and  CHs(19)-H(2O0). The con- 
figuration a t  C13 m ust be the  S-configuration, as no NOE 
contact is possible betw een H(13) and  CH3(16) in  the case 
of th e  ^-configuration .27 The configuration a t C4' m ust 
also be th e  £>-configuration because of th e  NOE contact 
betw een H(40 and H (2). In  th e  R -configuration these 
protons are in  the  trans-position ; such a  NOE contact, 
therefore, is no t possible. The S -configuration was
(27) Hoemann, M. Z.; Vander Velde, D.; Aube, J.; Georg, G. I.; 
Jayasinghe, L. R. J. Org. Chem. 1995, 60, 2918-2921.
i  I
22
tBuOOH
Pd(OAc)2
v*
X Ho
I I
24
assigned a t C4 and  the ^-configuration a t C5 because of 
the  NOE contact between CH3(19) and H(20/3).
Biological Evaluation
All the compounds 20, 21a,b, and 23-25 showed no 
or very slight in vitro cytotoxicity against seven well- 
characterized hum an  tum or cell lines.28 This lack of 
activity w as first attributed  to the missing benzoate 
group a t C2, an  assum ption in  agreem ent with SAR 
stud ies6c,7a,b*29 in  which it  was shown th a t the benzoate 
functionality  a t C2 is necessary for activity.
In  compounds 21a and 23 we hoped th a t the THP 
group and  th e  benzylidene acetal functionality could be 
a su b stitu te  for th e  benzoate group a t C2 , due to the two 
acetal oxygens, which are in about the same position as 
th e  two oxygens of the benzoate group. Compound 25 
could dem onstrate  th a t a benzoyl group at th is position 
does not have th e  same im portant influence on the 
activ ity  as th is  functionality has on C2 . Also, no cyto­
toxicity was found for compound 24, which has a benzoate 
group a t  C2.
Recent SAR studies on paclitaxel analogs with sub­
stituen t variations a t C4 have shown th a t the substituent 
at C4 is very im portan t for cytotoxic activity. 9b,13c,3° We 
suppose, therefore, th a t the lack of activity seen in the 
compounds presented here is probably due to the missing 
acetate  group a t  C4.
(28) (a) The determination of the cytotoxicity was carried out by H. 
J. Kolker, J. Verweij, G. Stoter, and J. H. M. Schellens, from the 
laboratory of Experimental Chemotherapy and Pharmacology, Depart­
ment of Medical Oncology. Rotterdam Cancer Institute (Dr. Daniel den 
Hoed Kliniek). (b) For details of the in vitro assay, see: Kepers, Y. P.; 
Pizao, P. E.; Peters, G. J.; Van Ark-Otte, J,; Winograd, B.; Pinedo, H. 
M. Eur. c/. Cancer 1991,27, 897—900. (c) The seven human tumor cell 
lines used for the cytotoxity tests were as follows: MCF7, breast cancer; 
EVSA-T, breast cancer; WIDR, colon cancer; IGROV, ovarian cancer; 
Ml9 MEL, melanoma; A498, renal cancer; H226, nonsmall cell lung 
cancer.
(29) (a) Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, 
M. D.; Gunatilaka, A. A. L.; Kingston, D. G. L; Grover, S.; Lin, C. M.; 
Hamel, E. J. Am. Chem. Soc. 1994,116, 4097-4098. (b) Nicolaou, K.
C.; Renaud, J.; Nantermet, P. G.; Couladouros, E. A.; Guy, E. A.; 
Wrasidlo, W. J. Am. Chem. Soc, 1995,117, 2409-2420.
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Our future synthetic program  is directed toward 
7-deoxypaclitaxel analogs th a t  possess a benzoate group 
a t C2 as well as an acetate group a t C4. Furtherm ore, 
the  conversion of compound 7b into 1,7-dideoxypaclitaxel 
analogs is now in progress.2111
Experim ental Section
Chemical shift values are reported as d-values relative to 
TMS as internal standard; deuteriochloroform was used as 
solvent. Mass spectra were obtained with a double-focusing 
spectrometer, Melting points are uncorrected.
Compounds 8b-14b were prepared as reported by Ettouati 
et al.11 The ^-NM R spectra of 8b-14b were in agreement 
with those reported in the literature.11
E xtrac tion  P rocedure fo r C rude Taxine B. Dried 
leaves (17 kg) of T. baccata were soaked in an aqueous solution 
of HgSOi (100 L, 0.5% v/v) for 3 days. The sulfuric acid 
solution was separated from the leaves and extracted (in 
portions of 20 L) with diethyl ether (3 L) in a continuous 
extraction apparatus for 1 d, in order to remove the major part 
of the undesirable neutral organic compounds. The sulfuric 
acid solution was brought to pH 9 by addition of aqueous 
ammonia. This solution was extracted twice with diethyl ether 
(3 L) in a continuous extraction apparatus for 1 d. The 
combined ether layers were dried over Na2S0 4 and concen­
trated in vacuo, yielding crude taxine (150-200 g from 17 kg, 
depending on the quality of the leaves) as a light yellow 
amorphous powder.
P rep a ra tio n  of the  M ixture of 5 a-f. To a solution of 
crude taxine B (containing 40% of 4a—f) (25.0 g, 42.9 mmol) 
in ether (150 mL) was added methyl iodide (12.5 mL), After
1 d the pale yellow amorphous iodide salt of 4 a - f  was 
collected, washed with ether, and dried (13.4 g, 18.3 mmol). A 
solution of this salt (13.4 g) in ethanol (50 mL) was added to 
a solution of K2CO3 (15.0 g) in water (750 mL). The reaction 
mixture was stirred for 2 h. The precipitated mixture of 5 a - f  
was collected, washed with water, and dried (9.50 g, 17.7 
mmol).
P rep a ra tio n  of the M ixture of 5a-Cinnamoyltaxicin-X 
(6a) and  5a-Cinnamoyltaxicin-II (6b). A solution of sodium 
methoxide prepared from 0.49 g of sodium (0.021 mol), in 
methanol (550 mL) was cooled to 0 °C under an argon 
atmosphere. After addition of 5a ~ f (9.50 g, 17.7 mmol), the 
mixture was stirred for 16 h at 0 °C. The reaction mixture 
was subsequently acidified with glacial acetic acid and con­
centrated, and water (500 mL) was added. This solution was 
extracted twice with ether (200 mL). The combined ether 
layers were washed with saturated NaHCOs solution, dried 
over Na2S04, and concentrated in vacuo, yielding a mixture 
of 6a,b (7.45 g, 15.0 mmol, 85%).
P rep ara tio n  of the  M ixture of 9,10-O-(Propane-2,2- 
diy3)-5a-cinnamoyltaxicin-I (7a) and  9,10-0-(Propane- 
2,2»diyl)-5a-cinnamoyltaxicin-II (7b). To a suspension of 
anhydrous CuS04 (35 g, 0.22 mol) in dry acetone (750 mL) 
was added the mixture of 6a,b (7.45 g, 15.0 mmol) and a 
catalytic amount ofp-toluenesulfonic acid were added. After
2 d at r t the solution was filtered. The filtrate was concen­
trated ¿?i vacuo. The residue was purified by chromatography 
(EtOAc/hexane 2/5) to give a mixture of 7a and 7b (5.23 g, 9.80 
mmol, 65%). '
1,2-DiCtetrahy dropyran-2-yl)-9,10-0 - (propane-2,2-diyl)- 
Sa-cinnamoyltaxicin-I (8a). To a solution of 7a,b (5.0 g, 9.4 
mmol) and p-toluenesulfonic acid (10 mg, 0.05 mmol) in CH2-
(30) (a) Neidigh, K. A.; Gharpure, M. M.; Rimoldi, J. M.; Kingston,
D. G. I.; Jiang, Y.Q.; Hamel, E. Tetrahedron Lett. 1994, 35, 6839— 
6842. (b) Chen, S.; Kadow, J. F.; Farina, V. Fairchild, C, R.; Johnston, 
K. A. J. Org. Chem. 1994,59, 6156-6158. (c) Klein, L. L.; Li, L.; Yeung, 
C. M.; Maring, C. J.; Thomas, S. A.; Grampovnik, D. J.; Plattner, J. J. 
In Taxane Anticancer Agents, Basic Science and Current Status; Georg,
G. I,, Chen, T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 
No. 583; American Chemical Society; Washington, DC, 1995; 276— 
287. (d) Chen, S.-H.; Wei, J.-M.; Long, B. H.; Fairchild, C. A.; Carboni, 
J.; Mamber, S. W.; Rose, W. C.; Johnston, K; Casazza, A. M.; Kadow, 
J. F.; Farina, V.; Vyas, D. M.; Doyle, T. W. Bioorg. Med. Chem. Lett. 
1995, 5, 2741-2746.
CI2 (75 mL) was slowly added dihydropyran (2.3 g, 27 mmol) 
in CH2CI2 (10 mL) at rt. After 1 d the reaction mixture was 
washed with saturated NaHC03 solution and brine, dried over 
Na2S04, and concentrated in vacuo. The residue was purified 
by chromatography (EtOAc/hexane 2/5), yielding 7b21 (0.68 g,
1.3 mmol, 14%) and 8a (5.4 g, 7.7 mmol, 82%); mp 66 °C; 1H- 
NMR (400 MHz, CDCI3) 6 7.73 (m,2H), 7.41 (m, 3H), 7.61 (d, 
J  = 15.9 Hz, 1H), 6.33 (d, J  = 15.9 Hz, 1H), 5.58 (bs, 1H), 
5.33 (s, 1H), 5.27 (bs, 1H), 4.91 (m, 1H), 4.90 (d, J  = 9.2 Hz, 
1H), 4.56 (m, 1H), 4,26 (d, J  = 9.2 Hz, 1H), 4.14 (d, J  =  5.6 
Hz, 1H), 3.85 (m, 1H), 3.73 (m, 1H), 3.49 (m, 1H), 3.39 (m, 
1H), 3.09 (d, J  = 5.6 Hz, 1H), 2.67 (s, 2H), 2.12 (s, 3H), 1.59 
(s, 3H), 1.50 (s, 3H)} 1.44 (s, 3H), 1.36 (s, 3H), 1.10 (s, 3H); 
FAB-MS 705 [M + H]+. Anal. Calcd for C42H5609: C, 71.57;
H, 8.01. Found: C, 71.91; H, 7.95.
l,2-0-Benzylidene-9,10-0-(propane-2,2-diyl)-5a-cinn-
am oyltaxicin-I (8c). The same procedure was followed as 
for 8a. Instead of dihydropyran, the dimethyl acetal of 
benzaldehyde (2.8 mL, 18.6 mmol) was added. Compound 8c 
was isolated in 85% yield (4.98 g, 7.98 mmol, 85%): mp 108- 
110 °C; FAB-MS 625 [M + H]+, 647 [M + Na]+. Anal. Calcd 
for C39H440 7: C, 74.98; H, 7.10. Found: C, 74.63; H, 7.23.
Hydrolysis of 8a to 9a. To a solution of 8a (5.4 g, 7.7 
mmol) in dry THF (60 mL) was added 20 N NaOH (aq) (25 
mL). The reaction mixture was stirred at reflux temperature 
for 2d . The reaction mixture was subsequently diluted with 
water (50 mL) and extracted twice with CH2CI2 (150 mL). The 
combined organic layers were washed with brine, dried over 
Na2S0 4, and concentrated in vacuo. The residue was purified 
by chromatography (EtOAc/hexane 1/1), yielding 9a (4.20 g, 
7.32 mmol, 95%): mp 66-69 °C; XH-NMR (400 MHz, CDCI3) 
5 5.47 (bs, 1H), 5.09 (bs, 1H), 4.91 (d, J  = 9.2 Hz, 1H), 4.89 
(m, 1H), 4.58, (m, 1H), 4.22 (d, J  =  9.2 Hz, 1H), 4.17 (bs, 1H), 
4.10 (d, J  =  5.4 Hz, 1H), 3.87 (m, 1H), 3.74 (m, 1H), 3.50 (m, 
1H), 3.40 (m, 1H), 3.23 (d, J  = 5.4 Hz, 1H), 2.60 (bs, 2H), 2.06 
(s, 3H), 1.58 (s, 3H), 1.49 (s, 3H), 1.45 (s, 3H), 1.32 (s, 3H),
I.05 (s, 3H); CIMS, 574 [M]+. Anal. Calcd for C33H50O8: C, 
68.95; H, 8.79. Found: C, 69.17; H, 8.63.
Hydrolysis of 8c to 9c. The same procedure was followed 
as for 9a, using 8c (4.98 g, 7.98 mmol). Compound 9c was 
isolated in 76% yield (3.00 g, 6.07 mmol): mp 180 °C; FAB- 
MS 495 [M + H]+. Anal. Calcd for CaoHasOr,: C, 72.85; H, 
7.74. Found: C, 72.51; H, 8.00.
Dihydroxyl at ion of 9a to 10a. To a solution of 9a (4.20 
g, 7.32 mmol) in THF/H2O (80/40 mL) were added A^-methyl- 
morpholine JV-oxide monohydrate (900 mg, 6.70 mmol) and a 
solution of 0 s0 4 (2.5% in ¿-BuOH, 6.4 mL). The reaction 
mixture rapidly turned red. After 20 h, Florisil (2.0 g), water 
(26 mL), and Na204S2 (256 mg) were added. The mixture was 
stirred for an additional 10 min and then filtered. The filtrate 
was diluted with a saturated solution of NH4C1 in water (100 
mL) and extracted twice with EtOAc (150 mL). The combined 
organic layers were washed with brine, dried over Na2S0 4, and 
concentrated in vacuo. The residue was purified by chroma­
tography (EtOAc), yielding 10a (3.33 g, 5.48 mmol, 75%): mp 
72 °C; JH-NMR (400 MHz, CDC13) <5 4,97 (m, 1H), 4.81 (d, J  =
9.3 Hz, 1H)S 4.55, (m, 1H), 4.15 (d, J  =  9.3 Hz, 1H), 4.09 (d, J  
=  4.9 Hz, 1H), 4.04 (bs, 1H), 3.87 (m, 1H), 3.82 (bs, 1H), 3.77 
(m, 1H), 3.59 (bs, 1H), 3.50 (m, 1H), 3.42 (m, 1H), 3.23 (d, J  =
19.3 Hz, 1H), 2.65 (d, J  =  4.9 Hz, 1H), 2.62 (d, J  = 19.3 Hz, 
1H), 2.03 (s, 3H), 1.56 (s, 3H), 1.46 (s, 3H), 1.43 (s, 3H), 1.34 
(s, 3H), 1.08 (a, 3H); FAB-MS 524 [M -  THP + H]+. Anal. 
Calcd for C33H52O10: C, 65.11; H, 8.61. Found: C, 64.72; H, 
8.28.
Dihydroxylation of 9c to 10c. The same procedure was 
followed as for 10a, using 9c (3.00 g, 6.07 mmol). Compound 
10c was isolated in 55% yield (1.77 g, 3.35 mmol): mp 133 
°C; FAB-MS 551 [M + Na]+. Anal. Calcd for CaoH4o08-HaO:
C, 65.90; H, 7.75. Found: C, 66.26; H, 7.57.
S ily lation  and M esylation of 10a  to  11a. A solution of 
imidazole (5.10 g, 74.8 mmol) and TBDMSC1 (4.64 g, 30.9 
mmol) in DMF (30 mL) was stirred for 15 min. Compound 
10a (3.33 g, 5.48 mmol) was subsequently added. After 3 h 
the reaction mixture was diluted with a solution of 10% citric 
acid in water (200 mL) and extracted twice with EtOAc (100 
mL). The combined organic layers were washed with brine,
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dried over NaaSO*, and concentrated in  vacuo . The residue 
was purified by chromatography (EtOAc/hexane 2/5), yielding 
the silylated compound (3.78 g, 5.23 mmol, 95%): mp 52 °C; 
FAB-MS 746 [M -b Na]+. Anal. Calcd for C39H66O10SMI2O:
C, 63.20; H, 9.27. Found: C, 63.56; H, 8.95.
To a solution of the silylated compound (3.78 g, 5.23 mmol) 
in pyridine (50 mL) at 0 °C was added MsCl (2.5 mL). The 
reaction mixture was stirred for 20 h at rt, after which time 
CH2CI2 (150 mL) was added. The mixture was washed with 
a solution of 10% citric acid in water (75 mL) and with 
saturated NaHCOy solution, dried over Na2S 0 4, and concen­
trated in vacuo. The residue was purified by chromatography 
(EtOAc/hexane 2/5), yielding 11a (3.70 g, 4.63 mmol, 89%): 
mp 57 °C; lH-NMR (400 MHz, CDC13) (5 4.94 (m, 1H), 4.86 
(bs, 1H), 4.80 (d, J  =  9.3 Hz, 1H), 4.57 (m, 1H), 4.18 (d, J  =
9.3 Hz, 1H), 4.12 (d, J  = 10.4 Hz, 1H), 4.02 (d, J  = 4.1 Hz, 
1H), 3.86 (m, 1H), 3.74 (m, 1H), 3.66 (d, J  = 10.4 Hz, 1H),
3.51 (m, 1H), 3.47 (d, J  = 19.4 Hz, 1H), 3.38 (m, 1H), 2.94 (s, 
3H), 2.56 (d, J  =  19.4 Hz, 1H), 2.51 (d, J  = 4.1 Hz, 1H), 2.07 
(s, 3H), 1.55 (s, 3H), 1.47 (s, 3H), 1.43 (s, 3H), 1.34 (s, 3H),
1.08 (s, 3H), 0.90 (s, 9H), 0.08 (s, 6H); FAB-MS 823 [M + Na]+. 
Anal. Calcd for C4oHs80i2SiS: C, 59.97; H, 8.56; S, 4,00. 
Found: C, 60.14; H, 8.47; S, 2.69.31
Silylation and M esylation of 10c to 11c. The same 
procedure was followed as for 11a, using 10c (1.77 g, 3.35 
mmol). The silylated compound was isolated in 93% (2,03 g, 
3.16 mmol) yield: mp 61 °C; FAB-MS, 665 [M + Na]+. Anal. 
Calcd for C36H540aSi: C, 67.26; H, 8.47. Found: C, 67.07; H, 
8.83.
Compound 11c was isolated in 83% yield (1.91 g, 2.65 
mmol): mp 199 °C; FAB-MS 743 [M 4- Na]+. Anal. Calcd for 
C37H56O10SiS: C, 61.64; H, 7.83; S, 4.45. Found: C, 61.35; H, 
8.09; S, 4.47.
Construction of the Oxetane Ring: 11a to 12a (Route
1). To a solution of 11a (3.70 g, 4.63 mmol) in THF (75 mL) 
was added tetrabutylammonium fluoride (1.8 g, 6.9 mmol). The 
reaction mixture was stirred for 1 h a t rt, after which time 
EtOAc (150 mL) was added. The organic layer was washed 
with saturated NaHCOa solution, dried over Na2S04, and 
concentrated in vacuo. The residue was purified by chroma­
tography (EtOAc/hexane 1/1), yielding the desilylated com­
pound (3.10 g, 4.52 mmol, 98%); mp 89 °C; FAB-MS, 687 [M
4 H]+, 709 [M 4  Na]+. Anal. Calcd for C34H540 i2S: C, 59.46;
H, 7.92; S, 4.67. Found: C, 59.35; H, 7.88; S, 3.31.31
To a solution of the desilylated compound (3.10 g, 4.52 
mmol) in butanone (75 mL) was added tetrabutylammonium 
acetate (12.0 g, 39.9 mmol). The reaction mixture was stirred 
at reflux temperature for 17 h. The mixture was diluted with 
EtOAc (100 mL) and washed with a saturated solution of NH4- 
C1 in water. The organic layer was dried over Na2S04 and 
concentrated' in vacuo. The residue was purified by chroma­
tography (EtOAc/hexane 2/5), yielding 12a (2.04 g, 3.46 mmol, 
77%): mp 65 °C; XH-NMR (400 MHz, CDC13) (3 4.94 (m, 1H),
4.86 (bs, 1H), 4.80 (d, J  -  9.3 Hz, 1H), 4.57 (m, 1H), 4.18 (d, 
J  = 9.3 Hz, 1H), 4.12 (d> J  = 10.4 Hz, 1H), 4.02 (d, J  = 4.1 Hz, 
1H), 3.86 (m, 1H), 3.74 (m, III), 3.66 (d, J  =  10.4 Hz, 1H),
3.51 (m, 1H), 3.47 (ds J  = 19.4 Hz, 1H), 3.38 (m, 1H), 2.94 (s, 
3H), 2.56 (d, J  =  19.4 Hz, 1H), 2.51 (d, J  =  4.1 Hz, 1H), 2.07 
(s, 3H), 1.55 (s, 3H), 1.47 (s, 3H), 1.43 (a, 3H), 1.34 (s, 3H),
1.08 (s, 3H); FAB-MS 591 [M -I- H]+, 613 [M 4- Na]+. Anal. 
Calcd for CssHsoOg: C, 67.09; H, 8.53. Found: C, 67.04; H, 
8.47.
Construction of the Oxetane Ring: 11c to 12c (Route
1). The same procedure was followed as for 12a, using 11c 
(1.91 g, 2.65 mmol). The desilylated compound was isolated 
in 98% yield (1.60 g, 2.64 mmol): mp 116-120 °C; FAB-MS 
629 [M 4- Na]+, Anal. Calcd for C31H42O10S: C, 61.37; H, 6.98; 
S, 5.28. Found: C, 61.06; H, 7.08; S, 4.63.31
Compound 12c was isolated in 64% yield (0.85 g, 1.7 
mmol): mp 109 °C; FAB-MS 533 [M + Na]+ A nal Calcd for 
CsoHgsOv-HsO: C, 68.15; H, 7.64. Found: C, 67.80; H, 7.59.
Reduction of 11a to 13a (route 2). To a solution of 11a 
(1.00 g, 1.25 mmol) in CH2CI2 (10 mL) at -1 0  °C was added a
(31) This compound was not obtained completely pure and was used 
as such in the next step.
solution of DIBALH in CH2CI2 (2.0 mL, 1 M, 2.0 mmol) was 
added. The reaction mixture was stirred at 0 °C for 3 h, after 
which time a solution of 10% citric acid in water (20 mL) was 
carefully added. The water layer was extracted twice with 
CH2CI2 (50 mL). The combined organic layers were washed 
with saturated NaHCOg solution and with brine, dried over 
Na2S04, and concentrated in vacuo. The residue was purified 
by chromatography (EtOAc/hexane 2/5), yielding 13a (0.47 g, 
0,59 mmol, 45%): mp 49 °C; 1H-NMR (400 MHz, CDCI3) 6 4.88 
(m, 2H), 4.74 (d, J  =  9.4 Hz, 1H), 4.58 (m, 1H), 4.43 (m, 1H), 
4.26 (d, J  =  10.5 Hz, 1H), 4.02 (d, J  = 9.4 Hz, 1H), 3.86 (m, 
2H), 3.74 (m, 1H), 3,63 (d, J  = 10.5 Hz, 1H), 3.51 (m, 1H), 
3.47 (s, 1H), 3.39 (m, 1H), 3.06 (s, 3H), 2.69 (d, J  = 4.0 Hz, 
1H), 2.41 (bd, J  =  6.3 Hz, 2H), 2.06 (s, 3H), 1.59 (s, 3H), 1.46 
(s, 3H), 1.43 (s, 3H), 1.40 (s, 3H), 1.06 (s, 3H), 0.91 (s, 9H), 
0.08 (s, 6H); FAB-MS: 825 [M 4  Na]+. Anal. Calcd for C40H70- 
0 12SiS: C, 59.82; H, 8.53; S, 3.99. Found: C, 59.74; H, 8.78;
S, 3.56.
2 -D eb enz oyl-1,2 - (dit etr ahy dr opyr an-2-yl)-4-deacetyl- 
7-deoxy-10-deacetyl-9,10-0-(propane-2,2-diyl)-9tR)-dihy- 
drobaccatin III (14a) (Route 1). The same procedure was 
followed as for 13a (route 2), using 12a (2.04 g, 3.46 mmol). 
Compound 14a was isolated in 49% yield (1.02 g, 1.72 mmol): 
mp 50 °C; ^-N M R  (400 MHz, CDCI3): <5 4.91 (m, 1H), 4.79 
(dd, J  = 8.0, 3.6 Hz, 1H), 4.65 (d, J  = 8.9 Hz, 1H), 4.62 (d, J  
= 8.0 Hz, 1H), 4.54 (m, 1H), 4,49 (d, J  = 8.0 Hz, 1H), 4.41 (m, 
1H), 4.10 (d, J  = 8.9 Hz, 1H), 3.98 (d, J  = 4.4 Hz, 1H), 3.91 
(m, 1H), 3.79 (m, 1H), 3.73 (s, 1H), 3.50 (m, 1H), 3.41 (m, 1H), 
2.43 (dd, J  =  16.0, 9.8 Hz, 1H), 2.16 (m, 2H), 2.00 (m, 2H), 
1.93 (s, 3H), 1.63 (s, 3H), 1,49 (s, 3H), 1.46 (s, 3H), 1.42 (s, 
3H), 1.13 (s, 3H); FAB-MS 615 [M + Na]+. Anal. Calcd for 
Ca3HBa09-H20 : C, 64.89; H, 8.91. Found: C, 65.25; H, 8.83.
2 -Debenzoyl-1,2 - (ditetr ahy dr opyr an-2-yl) -4-deacetyl- 
7-deoxy-10-deacetyl-9,10-0-(propane-2,2-diyl)-9(i?)-dihy- 
drobaccatin III (14a) (Route 2). The same procedure was 
followed as for 12a (route 1), using 13a (0.47 g, 0.59 mmol). 
The desilylated compound was not further purified.
Compound 14a was isolated in 79% yield (0.28 g, 0.47 
mmol): mp 49 °C; XH-NMR (400 MHz, CDCI3) was the same 
as for 14a in route 1 .
2-DebenzoyM,2-O-benzylidene-4-deacetyl-7-deoxy-10- 
deacetyl-9,10-0«(propane-2,2-diyl)-9(R)-dihydrobacca- 
tin  III (14c) (Route 1). The same procedure was followed 
as for 13a (route 2), using 12c (0.85 g, 1.7 mmol), Compound 
14c was isolated in 46% yield (0.40 g, 0.78 mmol): mp 105- 
108 °C; FAB-MS 535 [M + Na]+. Anal. Calcd for C30H4o0 7:
C, 70.29; H, 7.86. Found: C, 70.27; H, 8.00.
2-Debenz oyl-l,2-(dite trahy dr opyr an-2-yl)-4-deace tyl- 
7-deoxy-10-de acetyl-9,10-0-(propane-2,2-diyl)-2'-(ethoxy- 
ethyl)-9(jR)-dihydropaclitaxel (15a). To a solution of 14a 
(1.02 g, 1.72 mmol) in toluene (50 mL) were added DMAP (210 
mg, 1.72 mmol), pyridine (1 mL) and modified paclitaxel 
side chain26 (2.75 g, 7.99 mmol). The reaction mixture was 
stirred for 12 h at rt, after which time the reaction mixture 
was diluted with EtOAc (200 mL). This mixture was washed 
with a solution of 10% CuS04 in water (50 mL). The organic 
layer was dried over Na2S04 and concentrated in vacuo. The 
residue was purified by chromatography (EtOAc/hexane 2/5), 
yielding 15a (1.41 g, 1.51 mmol, 89%): mp 63 °C; 1H-NMR 
(400 MHz, CDCI3) 6 7.76 (m, 2H), 7.48 (m, 5H), 7.33 (m, 3H),
7.08 (d, J  =  10.3 Hz, 1H), 6.12 (d, J  =  10.3 Hz, 1H), 5.88 (m, 
1H), 4.95 (m, 1H), 4.79 (m, 1H), 4.61 (m, 3H), 4.47 (m, 3H), 
4.18 (m, 2H), 3.94 (bs, 1H), 3.78 (m, 1H), 3.63 (m, 1H), 3.47 
(m, 1H), 3.28 (m, 2H), 3.08-2.95 (dq, J  = 7.03 Hz, 1H), 2.24 
(m, 3H), 2.06 (m, 3H), 1.86 (s, 3H), 1.63 (s, 3H), 1.52 (s, 3H), 
1.46 (s, 3H), 1.43 (s, 3H), 1.26 (d, J  = 4.2 Hz, 3H), 1.19 (s, 
3H), 0.92-0.85 (dt, J  = 7.03 Hz, 3H); FAB-MS, 955 [M + Na]+ 
Anal. Calcd for C53H73N 0 13-0.5H20: C, 67,62; H, 7.94; N, 1.49. 
Found: C, 67.47; H, 7.58; N, 1.90.
2-D eb en zoyl-1,2-acetonide-4-deacetyl-7-deoxy-10- 
deacetyl-9,10-0-(propane-2,2-diyl)-2'-(ethoxyethyl)-9CR)-
dihydropaclitaxel (15b). The same procedure was followed 
as for 15a, using 14b (0.49 g, 1.1 mmol). Compound 15b was 
isolated in 66% yield (0.58 g, 0.72 mmol): mp 65 °C; FAB-MS 
804 [M 4- H]+, 826 [M 4- Na]+. Anal. Calcd for C46H61-
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NOLi‘H20: C, 67.20; H, 7.74; N, 1.70. Found: C, 67.53; H, 
7*70; N, 1.98.
2-Debenzoyl-1,2-0-benzylidene-4-de acetyl-7-deoxy^ 10- 
deace tyl'9,10-0-(propane-2,2-diyl)-2'-(ethoxy ethyl) 
dihydropaclitaxel (15c). The same procedure was followed 
as for 15a, using 14c (0.40 g, 0.78 mmol). Compound 15c was 
isolated in 70% yield (0.47 g, 0.55 mmol): mp 73 °C; FAB-MS 
874 [M + Na]+. Anal. Calcd for C50H61N 0 U-H20: C, 69.01;
H, 7.31; N, 1.61. Found: C, 68.94; H, 6.92; N, 1.90. 
Hydrolysis of 12a to 16. Compound 12a (1.00 g, 1.69
mmol) was dissolved in a mixture of HOAC/H2O/THF (68/34/ 
17 mL). After being stirred for 24 h at rt, the mixture was 
diluted with EtOAc (100 mL). The organic layer was washed 
w ith saturated NaHC03 solution (75 mL) and with brine. The 
organic layer was dried over Na2S04 and concentrated in 
vacuo. The residue was purified by chromatography (EtOAc/ 
hexane 1/1), yielding 16 (770 mg, 1.52 mmol, 89%); mp 67 °C; 
iH-NMR (400 MHz, CDC13) (3 4.94 (t, J  = 5.1 Hz, 1H), 4.96 
(dd, J  = 8.5, 2.2 Hz, 1H), 4.67 (d, J  =  9.4 Hz, 1H), 4.61 (d, J  
=  8.1 Hz, 1H), 4.37 (d, J  = 8.1 Hz, 1H), 4.26 (d, J  = 9.4 Hz, 
1H), 4.14 (d, J  =  5.4 Hz, 1H), 3.67 (m, 2), 3.07 (s, 1H), 3.05 (d, 
J  =  19.2 Hz, 1H), 2.59 (d, J  = 19.2 Hz, 1H), 2.02 (m, 3H), 1.93 
(s, 3H), 1.81 (d, J  = 5.3 Hz, 1H), 1.62 (s, 3H), 1.58 (s, 3H),
I.49 (s, 3H), 1.45 (s, 3H), 1.33 (s, 3H); FAB-MS 529 [M + Na]+. 
Anal. Calcd for C28H42O8: C, 66.38; H, 8.36. Found: C, 66.79;
H, 8,46.
Benzoylation of 16 to 17. To a solution of 16 (0.77 g, 1.5 
mmol) in EtOAc (10 mL) were added triethylamine (0.62 mL,
4.4 mmol), DMAP (1.16 g, 9.51 mmol), and benzoyl chloride 
(0.32 mL, 2.8 mmol). After the mixture was stirred for 24 h 
a t rt, EtOAc (50 mL) was added. The mixture was washed 
with a 10% citric acid solution in water (50 mL) and with brine, 
dried over NagSOi, and concentrated in vacuo. The residue 
w as purified by chromatography (EtOAc/hexane 2/5), yielding 
17 (891 mg, 1.46 mmol, 96%): mp 184 °C; ^-NM R (400 MHz, 
CDCI3) a 8.04 (dd, J  =  7.4, 1.2 Hz, 2H), 7.57 (t, J  = 7.4 Hz, 
1H), 7,45 (t, J  = 7.6 Hz, 2H), 4.97 (t, J  = 5.1 Hz, 1H), 4.78 
(dd, J  = 8.4, 2.1 Hz, 1H), 4.67 (d, J  = 9.4 Hz, 1H), 4.58 (d, J
-  8.1 Hz, 1H), 4.34 (m, 3H), 4.25 (d, J  = 9.4 Hz, 1H), 4.14 (d, 
J  =  5.4 Hz, 1H), 3.05 (d, J  =  19.2 Hz, 1H), 2.90 (s, 1H), 2.60 
(d, J  = 19.2 Hz, 1H), 2.02 (m, 3H), 1.93 (s, 3H), 1.82 (d, J  =
5.5 Hz, 1H), 1.58 (s, 3H), 1.55 (s, 3H), 1.49 (s, 3H), 1.45 (s, 
3H), 1.33 (s, 3H); FAB-MS 611 [M 4  H]+, 633 [M + Na]+. Anal. 
Calcd for C35H46O9: C, 68.83; H, 7.59. Found: C, 69.01; H, 
7.26.
1 -Benzoyl~2-debenzoyl-2- (tetrahydropyran-2-yl)-4- 
d e acetyl-7-deoxy-10-deacetyl-9,10-0-(propane-2,2-diyl)- 
9CR)-dihydrobaccatin III (18). To a solution of 17 (0.89 g,
I ,5  mmol) in dry THF (20 mL) was added BH3*THF (20 mL, 1 
M in THF, 20 mmol). After 3 h at rt, EtOAc (50 mL) was 
added. The mixture was washed with a 10% citric acid 
solution in water (50 mL) and with saturated NaHCOa 
solution, dried over Na2S04, and concentrated in vacuo. The 
residue was purified by chromatography (EtOAc/hexane 1/1), 
yielding 18 (192 mg, 0.314 mmol, 21%): mp 127 °C; iH-NMR 
(400 MHz, CDC13) 6 8.05 (d, J  = 7.4 Hz, 2H), 7.56 (t, J  = 7.3 
H z, 1H), 7.45 (t, J  =  7.7 Hz, 2H), 4.91 (t, J  = 5.1 Hz, 1H), 4.80 
(dd, J  =  10.0, 5.1 Hz, 1H), 4.62 (d, J  = 9.4 Hz, 1H), 4.61 (d, J  
=  8.1 Hz, 1H), 4.36 (m, 4H), 4.09 (d, J  = 9.4 Hz, 1H), 3.98 (d, 
J  -  5.4 Hz, 1H), 3.26 (s, 1H), 2.44 (d, J  = 16.0 Hz, 1H), 2.14 
(m, 2H), 2.03 (m, 3H)} 1.93 (s, 3H), 1.49 (s, 3H), 1.48 (s, 3H),
1.45 (s, 3H), 1.42 (s, 3H), 1.13 (s, 3H); FAB-MS 635 [M + Na]+. 
Anal. Calcd for C35H4809«H20: C, 66.63; H, 8.01. Found: C, 
66.31; H, 7.96,
l-Benzoyl-2-debenzoyl-2-(tetrahydropyran-2-yl)-4- 
deacetyl-7-deoxy-10-deacetyl-9,10-0-(propane-2,2-diyl)- 
2'-(ethoxyethyl)-9tR)-dihydropaclitaxel (19). The same 
procedure was followed as for 15a, using 18 (0.19 g, 0.31 
mmol). Compound 19 was isolated in 80% yield (240 mg, 0.252 
mmol): mp 141 °C; XH~NMR (400 MHz, CDCI3) (5 8.01 (d, J  =
7.7 Hz, 2H), 7.83 (d, J  =  7.2 Hz, 2H), 7.75 (m, 2H), 7.40 (m, 
9H), 7.07 (d, J  =  9.6 Hz, 1H), 6.13 (d, J  = 9.7 Hz, 1H), 5.85 
(m, 1H), 4.94 (bd, J  =  5.5 Hz, 1H), 4.81 (m, 1H5), 4.65 (d, J  =
9.5 Hz, 1H), 4.59 (d, J  = 7.9 Hz, 1H), 4.48 (m, 2H), 4.19 (m, 
4H), 3.96 (d, J  =  5.3 Hz, 1H), 3.25-2.98 (m, 2H), 2.25 (m, 2H),
2.05 (m, 4H), 1.88 (s, 3H), 1.52 (s, 3H), 1.47 (s, 3H), 1.44 (s,
3H), 1.37 (dd, J  = 5.5 Hz, 3H), 1.26 (s, 3H), 1,19 (s, 3H), 0.92 
(dt, J  =  7.0 Hz, 3H); FAB-MS, 974 [M + Na]+. Anal. Calcd 
for C65H69N0i3-H20: C, 68.08; H, 7.39; N, 1.44. Found: C, 
67.83; H, 7.13; N, 1.44.
2-Debenzoyl-2-(tetrahydropyran-2-yl)-4-de acetyl-7- 
de oxy-10-de acety 1-9,10 - O - (propane-2,2 - diyl) - 9 (ii )-d ihy­
dropaclitaxel (20). Compound 15a (0.25 g, 0.27 mmol) was 
dissolved in HOAC/THF/H2O (8/4/8 mL). After 20 h at r t  the 
reaction mixture was diluted with EtOAc (50 mL). The organic 
layer was washed with saturated NaHCOs solution (20 mL), 
dried over Na2S04, and concentrated in  vacuo. The residue 
was purified by chromatography (EtOAc/hexane 1/1), yielding
20 (159 mg, 0.205 mmol, 76%): mp 115 °C; ^-NM R (400 MHz, 
CDCI3) Ó 7.72 (d, J  =  7.4 Hz, 2H), 7.58 (d, J  = 7.5 Hz, 2H), 
7,40 (m, 6H), 7.03 (d, J  =  9.5 Hz, 1H), 5.98 (bd, J  = 10.0 Hz, 
1H), 5.95 (m, 1H), 4.92 (bd, J  =  7.4 Hz, 1H); 4.86 (t, J  -  4.7 
Hz, 1H), 4.60 (m, 3H), 4,49 (d, J  = 8.0 Hz, 1H), 4.25 (s, 1H), 
4.15 (d, J  =  9.5 Hz, 1H), 3.98 (d, J  =  5.3 Hz, 1H), 3.59 (bs, 
1H), 3.53 (t, J  =  5.5 Hz, 2H), 2.39 (dd, J  =  15.9, 3.7 Hz, 1H), 
2.23 (m, 2H), 2.07 (d, 5.3 Hz, 1H), 2.00 (m, 3H), 1.73 (s, 
3H), 1.55 (s, 3H), 1.53 (s, 3H), 1.46 (s, 3H), 1.42 (s, 3H), 1.46 
(s, 3H); FAB-MS 776 [M 4- HF, 798 [M + Na]+. Anal. Calcd 
for C44HG7N 0ii-H 20: C, 66.55; H, 7,49; N, 1.76, Found: C, 
66.51; H, 7.40; N, 1.73.
2-Debenzoyl-2-(tetrahydropyran-2-yl)-4-deacetyl-7- 
deoxy-10-deacetyI-9(/2)-dihydropaclitaxel (21a). Com­
pound 15a (0.20 g, 0.21 mmol) was dissolved in HOAc/THF/ 
H2O (12/3/6 mL). The reaction mixture was stirred for 24 h 
at 40 °C. The reaction mixture was diluted with EtOAc (50 
mL), The organic layer was washed with saturated NaHCOa 
solution (20 mL), dried over Na2S04, and concentrated in 
vacuo . The residue was purified by chromatography (EtOAc/ 
hexane 7/3), yielding 21a (97 mg, 0.13 mmol, 63%): mp 198 
°C; XH-NMR (400 MHz, CDC13) Ò 7.74 (d, J  -  7.3 Hz, 2H), 7,56 
(d, J  =  7.6 Hz, 2H), 7.40 (m, 6H), 7.09 (d, J  = 9.5 Hz, 1H), 
5.97 (bd, J  =  9.4 Hz, 1H), 5,89 (m, 1H), 4.91 (dd, J  = 8.8, 2.1 
Hz, 1H), 4.86 (t, J  = 5.3 Hz, 1H), 4.62 (m, 3H), 4.48 (d, J  = 
8.0 Hz, 1H), 4.15 (bs, 1H)> 3.97 (d, J  = 9.5 Hz, 1H), 3.93 (d, J  
= 5.4 Hz, 1H), 3.70 (bs, 1H), 3.54 (t, J  =  5.5 Hz, 2), 2.75 (bs, 
1H), 2.50 (bs, 1H), 2.36 (dd, J  =  15.8, 3.5 Hz, 1H), 2,27 (d, J  
= 5,3 Hz, 1H), 2.22 (dd, J  = 15.7, 6,3 Hz, 1H), 2.00 (m, 5H),
1.67 (s, 3H), 1.55 (s, 3H), 1,48 (s, 3H), 1.16 (s, 3H); FAB-MS 
736 [M + H]+, 758 [M + Na]+ Anal. Calcd for C41H53- 
N O irH 20: C, 65.32; H, 7.35; N, 1.86. Found: C, 65.02; H, 
7.40; N, 1.80.
2-D ebenzoyl-l,2«ace tonide-4-deacetyl-7-de oxy-9-dihy­
dro-10-deace tylpaclitaxel (21b). The same procedure was 
followed as for 21a, using 15b (0.20 g, 0,25 mmol). Compound 
21b was isolated in 66% yield (114 mg, 0,165 mmol): mp 150 
°C; FAB-MS 692 [M 4  H]+, 714 [M + Na]+. Anal. Calcd for 
C39H49NOxo*l.5H 2O: C, 65,15; H, 7.31; N, 1,95. Found: C, 
65.29; H, 7.22; N, 1.92.
2-Debenzoyl- l,2-0-benzylidene-4«deacetyl-7-deoxy-10- 
deacetyl-9 ,10-0-(propane-2,2-diyl)-9(jR)-dihydropacli- 
taxel (22). Compound 15c (0.20 g, 0.24 mmol) was dissolved 
in HOAc/THF/HzO (8/4/8 mL). After 2 h at r t the reaction 
mixture was diluted with EtOAc (50 mL), The organic layer 
was washed with saturated NaHCOa solution (20 mL), dried 
over Na2S04, and concentrated in vacuo . The residue was 
purified by chromatography (EtOAc/hexane 1/1), yielding 22 
(136 mg, 0.175 mmol, 73%): mp 99 °C; XH-NMR (400 MHz, 
CDCI3): & 7.71-7.15 (m, 15H), 7.10 (d, J  = 7.9 Hz, 1H), 5.95 
(bd, J  =  9.2 Hz, 1H), 5.90 (m, 1H), 5.74 (s, 1H), 4.90 (dd, J  =
6.7 Hz, J  =  1.8 Hz, 1H), 4.67 (d, J  =  8.1 Hz, 1H), 4,62 (bs, 
1H), 4.59 (d, J  =  9.5 Hz, 1H), 4.44 (d, J =  8.2 Hz, 1H), 4.25 (d, 
J  =  5.2 Hz, 1H), 4.21 (d, J  =  9.5 Hz, 1H), 3.91 (s, 1H), 3.75 
(bs, 1H), 2.45 (m, 2H), 2.24 (m, 2H), 2.20 (d, J  =5.2 Hz, 1H),
1.67 (s, 3H), 1.63 (s, 3H), 1.59 (s, 3H), 1.49 (s, 3H), 1.43 (s, 
3H), 1.23 (a, 3H); FAB-MS 802 [M +  Nal+. Anal. Calcd for 
C46H53N Oio*0.5H20: C, 70.03; H, 6.89; N, 1.78. Found: C, 
69.93; H, 6.54; N, 2.13.
2-Debenzoyl-1,2-0-benzylidene)-4-deacety 1-7-deoxy- 
10-de ace tyl-9(R)-dihydropaclitaxel (23). The same pro­
cedure was followed as for 21a, using 15c (0,10 g, 0.12 mmol). 
Compound 23 was isolated in 68% yield (60 mg, 0.081 mmol): 
mp 144 °C; FAB-MS 740 [M + H]+, 762 [M +  Na]+. Anal.
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Caled for C43H49N O10-H2O: C, 68.14; H, 6.80; N, 1.85. 
Found: C, 67.81; H, 6.57; N, 2.15.
4-Deacetyl-7-deoxy-l 0-deacetyl-9,10-0-(propane-2,2- 
diyl)-9CR)-dihydropaclitaxel (24). To a solution of 22 (0.10 
g, 0.13 mmol) in toluene (5 mL) were added a solution of 
¿-BuOOH in decane (26 ¿¿L, 5.0—6.0M) and Pd(OAc)2 (2.4 mg, 
0.011 mmol). The reaction mixture was stirred at 50 °C for 
24 h. The reaction mixture was diluted with EtOAc (20 mL) 
and filtered over Hyflo. The filtrate was washed with water 
and brine. The organic layer was dried over Na2SÜ4 and 
concentrated in vacuo. The residue was purified by chroma­
tography (EtOAc/hexane 1/1), yielding 24 (29 mg, 0.036 mmol, 
28%): mp 125-128 °C; ^ -N M R  (400 MHz, CDC13) ó 8.23 (d, 
J  = 7.5 Hz, 2H), 7.78 (d, J  =  7.3 Hz, 2H), 7.60 (d, J  = 7.4 Hz, 
2H), 7.42 (m, 9H), 7,07 (d, J  = 9.6 Hz, 1H), 6.16 (d, J  = 9.5 
Hz, 1H), 6.01 (m, 1H), 5.87 (d, J  = 5.2 Hz, 1H), 4.89 (dd, J  = 
6.7, 1.8 Hz, 1H), 4.70 (d, J  = 9.5 Hz, 1H), 4.67 (bs, 1H), 4.40 
(d, J  = 9.6 Hz, 1H), 4.34 (d, J  = 7.9 Hz, 1H), 4.19 (d, J  =  7.9 
Hz, 1H), 3.41 (bs, 1H), 2.91 (dd, J  =  15.7, 3.6 Hz, 1H), 2.55 (d, 
J  = 5.2 Hz, 1H), 2.30 (dd, J  = 15.7, 6.4 Hz, 1H), 2.05 (m, 4H),
1.90 (s, 1H), 1.85 (s, 3H), 1.53 (s, 3H), 1.52 (s, 3H), 1.46 (s, 
3H), 1.43 (s, 3H16), 1.19 (a, 3H); FAB-MS 796 [M + H]+, 818 
[M + Na]+. Anal. Caled for C46H63N0n«1.5H20: C, 67.08;
H, 6.85; N, 1.78. Found: C, 66.77; H, 6.67; N, 2.00.
l-Benzoyl-2-debenzoyl-2-(tetrahydropyran-2-yl)-4- 
deacetyl-7-deoxy-lG-deacetyl-9(R)-dihydropaclitaxel (25), 
Compound 19 (0.10 g, 0.12 mmol) was dissolved in HOAc/THF/ 
H2O (36/3/6 mL). After 24 h at 50 °C, the reaction mixture 
was diluted with EtOAc (50 mL). The organic layer was
washed with saturated NaHCOa solution (20 mL), dried over 
Na2S0 4, and concentrated in vacuo. The residue was purified 
by chromatography (EtOAc/hexane 1/1), yielding 25 (61 mg,
0.073 mmol, 61%): mp 122 °C; 1H-NMR (400 MHz, CDClg) ö
8.02 (dd, J  = 7.8, 1.4 Hz, 2H), 7.73 (dd, J  = 7.8, 1.6 Hz, 2H), 
7.55 (m, 3H), 7.37 (m, 8H), 7.05 (d, J  = 9.5 Hz, 1H), 6.02 (bd, 
J  =  9.5 Hz, 1H), 5.88 (m, 1H), 4.91 (dd, J  = 8.9, 2.3 Hz, 1H),
4.86 (t, J  = 5.6 Hz, 1H), 4.62 (m, 3H), 4.44 (d, J  = 7.9 Hz, 
1H), 4.24 (m, 2H), 4.09 (s, 1H), 3.98 (d, J  = 9.4 Hz, 1H), 3.93 
(d, J  =  5.5 Hz, 1H), 3.70 (bs, 1H), 2.66 (bs, 1H), 2.35-1.99 (m, 
8H), 1.68 (s, 3H), 1.58 (s, 3H), 1.48 (s, 3H), 1.16 (s, 3H); FAB- 
MS, 840 [M + H]+, 862 [M + Na]+. Anal. Calcd for C48H57- 
NOi2: C, 68.62; H, 6.85; N, 1.67. Found: C, 68.38; H, 7.05; 
N, 1.41.
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